Nacre Capital is a global venture builder that creates, builds, and grows disruptive startups with deep technologies designed to significantly impact lives. The company identifies fundamental needs and develops groundbreaking solutions across sectors including health, biotechnology, agriculture, aquaculture, security, and culture. Nacre takes a hands-on approach to company creation, recruiting talented teams and providing financial, business development, and legal support. The company's portfolio includes notable ventures such as FDNA (digital health and AI for rare diseases), Fairtility (AI-based embryo selection for IVF), CureSign (cancer treatment monitoring), Seed-X (AI-based seed analysis), and Aquaticode (precision farming for aquaculture). Nacre's competitive advantage is built on deep R&D, with over 200 academic papers, 500+ research collaborations, and 140+ granted patents.
Beta · Sourced from candidate reports
Be the first to share your experience with Nacre Capital.
Your reply helps other candidates know what to expect.
